Correlation Between NextCure and Trevi Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NextCure and Trevi Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NextCure and Trevi Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NextCure and Trevi Therapeutics, you can compare the effects of market volatilities on NextCure and Trevi Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NextCure with a short position of Trevi Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NextCure and Trevi Therapeutics.

Diversification Opportunities for NextCure and Trevi Therapeutics

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between NextCure and Trevi is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and Trevi Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trevi Therapeutics and NextCure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NextCure are associated (or correlated) with Trevi Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trevi Therapeutics has no effect on the direction of NextCure i.e., NextCure and Trevi Therapeutics go up and down completely randomly.

Pair Corralation between NextCure and Trevi Therapeutics

Given the investment horizon of 90 days NextCure is expected to generate 6.81 times less return on investment than Trevi Therapeutics. In addition to that, NextCure is 1.05 times more volatile than Trevi Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Trevi Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest  219.00  in Trevi Therapeutics on September 12, 2024 and sell it today you would earn a total of  31.00  from holding Trevi Therapeutics or generate 14.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

NextCure  vs.  Trevi Therapeutics

 Performance 
       Timeline  
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Trevi Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Trevi Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

NextCure and Trevi Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NextCure and Trevi Therapeutics

The main advantage of trading using opposite NextCure and Trevi Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NextCure position performs unexpectedly, Trevi Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trevi Therapeutics will offset losses from the drop in Trevi Therapeutics' long position.
The idea behind NextCure and Trevi Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Transaction History
View history of all your transactions and understand their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins